Rebranded OEM Partner Vantage MedTech represents a merger of RBC Medical Innovations and Sterling Medical Devices, signaling a broader combined capability in concept-to-production services. This presents cross-sell opportunities to clients familiar with either legacy brand and potential expansion into Sterlings’ network.

Full Lifecycle Support Offerings cover feasibility, development, prototyping, clinical and commercial manufacturing, and after-market services. Target medical startups and OEMs seeking a single partner to manage product life cycle, reducing vendor fragmentation and speed to market.

Advantage Platforms Proprietary platforms aim to accelerate development timelines. Sales approach can emphasize reduced development risk and faster revenue ramp for clients pursuing First-in-Human and limited-quantity builds leading to full-scale launches.

Scale capable Capabilities to handle small-quantity clinical builds through full launch quantities suggest a fit for both early-stage trials and later-stage production. Propose engagement for Phase I–III programs and potential platform licensing or long-term outsourcing deals.

Strategic Growth Fit Recent private equity activity and the merger with Sterling Medical Devices indicate a growth trajectory and capital backing. Position as a stable, scalable partner for mid-market MedTech companies seeking strategic collaboration and resilient supply chain partnerships.